Opioid receptors have been heavily linked to prostate cancer biology [105], [106] and some have been proposed as potential targets such as OPRK1 [107] which hints at the possibility of NPBWR1 being able to be targeted in a similar way. This evidence concerns the gene OPRK1 and prostate cancer.